Drug Approval | April 14, 2026
FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
Highlights Mirvetuximab-based regimen promise
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
20 among them to receive $20,000 grants
The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets
Subscribe To Our Newsletter & Stay Updated
